Loading clinical trials...
Loading clinical trials...
A Multi-center, Randomized, Controlled Trial of Brexpiprazole for the Treatment of Co-occurring Schizophrenia and Substance Use Disorder
Conditions
Interventions
Brexpiprazole
Treatment as Usual
Locations
4
United States
Augusta University
Augusta, Georgia, United States
Massachusetts General Hospital
Boston, Massachusetts, United States
UMass Medical School
Worcester, Massachusetts, United States
University of North Carolina
Chapel Hill, North Carolina, United States
Start Date
June 19, 2018
Primary Completion Date
February 29, 2024
Completion Date
February 29, 2024
Last Updated
May 23, 2025
NCT06894212
NCT06413979
NCT04226898
NCT05492825
NCT05240976
NCT04197921
Lead Sponsor
University of Massachusetts, Worcester
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions